Jessica Perl serves as SVP, General Counsel, Corp Sec at Emergent BioSolutions Inc., where they oversee executive responsibilities. Since joining the company, Jessica Perl has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 9, 2026 involved selling 918 shares valued at $10.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | EBS | $10.1K | Payment | 918 | $11.03 | Discretionary |
Jessica Perl currently holds 67,469 shares of Emergent BioSolutions Inc. (EBS), valued at approximately $0. This represents their equity stake as SVP, General Counsel, Corp Sec.
Based on SEC Form 4 filings, Jessica Perl has been a net neutral trader of EBS stock. They have purchased $0 and sold $0 worth of shares.
Jessica Perl's most recent insider trade was on Feb 9, 2026, when they sold 918 shares at $11.03 per share.
Get notified when new Form 4 filings are submitted